DoD Funds Study For Early COVID-19 Symptom Detection Wearable mhealthintelligence.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mhealthintelligence.com Daily Mail and Mail on Sunday newspapers.
News Category Global Banking & Finance Reviews
Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection
December 22, 2020
Cambridge, MA –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and
BioIntelliSense, Inc. [1], a continuous health monitoring and clinical intelligence company, today announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms. The goal of the award is to accelerate the use of wearable diagnostics for the benefit of military and public health through the early identification and containment of pre-symptomatic COVID-19 cases.
December 22, 2020
Cambridge, MA –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and
BioIntelliSense, Inc. [1], a continuous health monitoring and clinical intelligence company, today announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms. The goal of the award is to accelerate the use of wearable diagnostics for the benefit of military and public health through the early identification and containment of pre-symptomatic COVID-19 cases.
First, let’s talk about logistics. Back in April,
Rolling Stone reported on the concept of immunity certificates or passports some type of documentation (electronic or paper) that would serve as proof that a person is immune from the novel coronavirus. And though much has changed since then both in terms of understanding the virus and now having two safe and effective vaccines Dr. L.J. Tan, an immunologist and the chief strategy officer of the Immunization Action Coalition (IAC), says that policies like these are still premature from a scientific standpoint.
Specifically, it is not yet known how long immunity from the Covid vaccine will last. “We haven’t got six months, nine months of duration of protection data yet,” Tan tells
National Lipid Association Releases Official Scientific Statement on Coronary Artery Calcium Scoring for ASCVD Risk Reduction
JACKSONVILLE, Fla., Dec. 12, 2020 (GLOBE NEWSWIRE) The National Lipid Association (NLA) today announced the release of its official scientific statement on coronary artery calcium (CAC) scoring for atherosclerotic cardiovascular disease (ASCVD) risk reduction. The statement provides updates on the evidence-based appropriate use of CAC scoring and makes practical recommendations to aid clinicians in primary prevention treatment decision-making in contemporary clinical practice.
“Coronary calcium scoring is the best available non-invasive marker of cardiovascular risk,” Stated the corresponding author, Carl E. Orringer, MD, Associate Professor Medicine at the University of Miami, Miller School of Medicine, Cardiovascular Division. “This manuscript addresses the key questions that clinicians have about this test and provides up-to-date, evidence-based r